Skip to content Skip to footer
Subscribe Now
Oncology Top 20 2024
TOP 20

Top 20 Oncology Companies of 2024

Shots:With more than 50 percent of ongoing clinical trials, Oncology remains one of the most explored therapy areas in healthcareIn 2023, the global oncology market was valued at $222.36B and is envisioned to grow to $521.6B by 2033, registering a CAGR of 8.9% from 2024 to 2033. With $27.6B registered oncology revenue, Merck…
August 29, 2024

Read more

Disease of the Month – Gaucher Disease
INSIGHTS+

Disease of the Month – Gaucher Disease

Shots: Gaucher disease is a rare, autosomal recessive disorder that enlarges organs like the bone marrow, liver, and spleen by depositing fats (lipids) in them In this reprise of our Disease of the Month report, we present an enlightening description of Gaucher disease with a thorough study of epidemiology, market size, disease management, potential medicines,…
August 28, 2024

Read more

Immunology Top 20 2024
TOP 20

Top 20 Immunology Companies of 2024

Shots:Immunology remains one of the most explored therapy areas. Companies focusing on immunology are steadfastly working to advance treatment options by developing drugs, vaccines, and antibodiesIn 2023, the global immunology market size was valued at $98.22B and expected to register $263.22B by 2033, with a CAGR of 10.36% from 2024 to 2033. AbbVie…
July 25, 2024

Read more

Know Your Investor: Invus (July’24 Edition)
INSIGHTS+

Know Your Investor: Invus (July’24 Edition)

Shots:   Backed with an evergreen investment strategy, Invus makes investments across several company stages ranging from early growth to turnarounds  In 2023, Invus participated in 6 investment rounds in around 29 companies focusing on biopharma, manufacturing & services, and devices  For a curated report on a specific investor or venture capital, reach out to us…
July 17, 2024

Read more

Vaccines Top 20 2024
TOP 20

Top 20 Vaccines of 2024

Shots:Vaccines play an instrumental role in curbing infectious diseases by generating antibodies against antigens and creating a memory to defeat them. Several biopharma companies are steadfastly working to deliver vaccines against infectious and vaccine-preventable diseases around the worldIn 2024, the global vaccine market is estimated to be around $78B and is expected to…
July 11, 2024

Read more

Know Your Investor (June Edition): Google Ventures
INSIGHTS+

Know Your Investor (June Edition): Google Ventures

Shots:Google Ventures is an investment arm of Alphabet Inc. That invests profusely in seed-stage companies ranging from software and internet to healthcare, life sciences, and artificial intelligence among othersEver since 2016, GV pivoted to focusing on established companies. The company manages assets worth $10B and 400 active portfolio companies spanning across North America…
June 13, 2024

Read more

Nutraceutical Top 20 2024
TOP 20

Top 20 Nutraceutical Companies of 2024

Shots:Nutraceuticals offer miraculous health benefits by enhancing body function and assisting in body repair and growthIn 2023, the global Nutraceuticals market was valued at $419.93B and is expected to increase from $457.35B in 2024 to $976.74B by 2032 with a CAGR of 9.95 percent. Nestlé ranks first on our list with reported segment…
June 6, 2024

Read more

Load more